This part mainly demonstrated that LIPUS stimulus could up-regulate mechanosensitive ion channel Piezo1 expression, then activating the TGFβ1 signal. Upon TGFβ1 signal activation, the Notch signal was inhibited, consequently leading to chondrogenic transdifferentiation of rat VSMCs. First, to identify the underlying changes of gene expression pattern and signal pathway, we performed RNA-sequencing analyses in rat VSMCs after LIPUS treatment in vitro. The genes were differentially expressed after LIPUS treatment (Fig.
3A). Moreover, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses revealed that calcium signaling pathway, TGFβ signaling pathway, and Notch signaling pathway were involved (Fig.
3B). Second, we identified that LIPUS stimulus could up-regulate Piezo1 expression, then inhibiting the Notch signal, consequently initiating chondrogenic transdifferentiation of VSMCs. LIPUS could provide acoustic mechanical stimulation, which inspired us to focus on mechanics-sensing molecules as downstream effectors. The mechanosensitive ion channel Piezo1 was the best characterized biological force-sensing system [
34]. Previous studies demonstrated that Piezo1 mediated the transformation of ultrasound acoustic mechanical stimulus into biochemical effect [
13]. The mRNA and protein levels of Piezo1 were up-regulated significantly in rat VSMCs after treatment with LIPUS (Fig.
3C and D). The KEGG pathway enrichment analysis demonstrated that the Notch signaling pathway was involved during chondrogenic transdifferentiation of VSMCs. The activation of Notch signaling played a critical role in maintaining contractile phenotype of VSMCs, while the chondrogenic transdifferentiation would be initiated upon repression of the Notch signal [
11]. After LIPUS treatment, the mRNA level of Notch ligand (Jag1) was down-regulated significantly. The mRNA level of Notch receptor (Notch1) was up-regulated significantly, while the mRNA level of Notch receptor (Notch3) was down-regulated significantly. The downstream target effector of the Notch signal (Hey1) was down-regulated significantly, demonstrating repression of the Notch signal. The protein levels of Notch1 and Hey1 were consistent with the mRNA level, demonstrating Notch1 up-regulation and Hey1 down-regulation (Fig.
3C and D). However, the protein level of Jag1 was up-regulated significantly after LIPUS treatment, which may be attributed to different chondrogenic transdifferentiation stages [
35]. The up-regulation of the Jag1 and Notch1 protein level was contradictory to the down-regulation of Hey1, which may be attributed to the complexity of the Jag/Notch signal. The Jag/Notch signal contained 5 kinds of ligands (Jag1, Jag2, Dll1, Dll3, and Dll4) and 4 kinds of receptors (Notch1, Notch2, Notch3, and Notch4) [
36]. However, the downstream target effector Hey1 could reflect the activation degree of the Notch signal. Until now, we have identified that LIPUS could up-regulate Piezo1 expression and repressed the Notch signal. In order to further elucidate the relation between the Piezo1 and Notch signal, the Piezo1 agonist (YODA1) and antagonist (GsMTx-4) were applied. After YODA1 treatment, the typical fibrochondrogenic marker (COL1A1 and COL2A1) was up-regulated significantly in the protein level, although the chondrogenic transcriptional factor (SOX9 and RUNX1) was not up-regulated, while the addition of GsMTx-4 repressed the effect of YODA1 on chondrogenic transdifferentiation, demonstrating down-regulation of COL2A1. Especially, the YODA1 treatment repressed the Notch signal, demonstrating down-regulation of Jag1, Notch1, and Hey1, while the addition of GsMTx-4 reversed the effect of YODA1 on the Notch signal in some degree, demonstrated by up-regulation of Hey1 (Fig.
3E and F). Additionally, in order to confirm the direct evidence that LIPUS promoted VSMC transdifferentiation into chondrocyte-like cells through Piezo1, GsMTx-4 was added during LIPUS treatment. The immunofluorescent results demonstrated that LIPUS treatment promoted VSMC transdifferentiation into chondrocyte-like cells, demonstrating down-regulation of α-SMA and SM22α and up-regulation of SOX9 and COL II, while GsMTx-4 blocked LIPUS effects (Fig.
S6). Therefore, LIPUS stimulus up-regulated Piezo1 expression, then repressing the Notch signal, consequently initiating chondrogenic transdifferentiation of VSMCs. Third, we identified that LIPUS activated the TGFβ1 signal, then inhibiting the Notch signal, consequently initiating chondrogenic transdifferentiation of VSMCs. As aforementioned, the KEGG enrichment analysis revealed that the TGFβ signaling pathway was involved after LIPUS treatment. Previous studies demonstrated that the elevated activation of TGFβ signaling was a critical modulator driving the chondrogenic transdifferentiation of VSMCs [
37]. After LIPUS treatment, the mRNA levels of TGFβ1, smad2, and smad3 were up-regulated significantly (Fig.
4A). Moreover, the protein levels of activated TGFβ1, smad2/3, and phosphorylated smad2/3 (pSmad2/3) were up-regulated (Fig.
4B). However, the protein level of non-activated TGFβ1 decreased significantly, which could be explained by the intrinsic feedback regulation of the TGFβ signal [
38]. After treatment with chondrogenic medium containing TGFβ1 (10 ng/ml), the Jag/Notch signal was repressed significantly, demonstrating down-regulation of Jag1, Notch3, and downstream target effectors (Hey1, Hey2, and Hes1). The fibrochondrogenic markers, including COL1A1, COL2A1, aggrecan, SOX9, and RUNX1, were up-regulated significantly (Fig.
4C and D). Therefore, we confirmed that LIPUS activated the TGFβ1 signal, then repressing the Notch signal, consequently enhancing chondrogenic transdifferentiation of VSMCs. Lastly, to identify the relation between the Piezo1 and TGFβ1 signal, the Piezo1 agonist (YODA1) and antagonist (GsMTx-4) were applied. The YODA1 treatment activated the TGFβ1 signal, while GsMTx-4 reversed the effect (Fig.
4E and F). Therefore, Piezo1 was the upstream of the TGFβ1 signal. Thus, we identified that LIPUS stimulus up-regulated Piezo1 expression, then activating the TGFβ1 signal. Upon TGFβ1 signal activation, the Notch signal was repressed, consequently initiating chondrogenic transdifferentiation of VSMCs (Fig.
4G).